Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: Observations from the Seattle Midlife Women's Health Study

Journal of Women's Health

Volumn 16, Issue 5, 2007, Pages 667-677

  Woods, Nancy Fugate ^a   Smith Dijulio, Kathleen ^a   Percival, Donald B ^a   Tao, Eunice Y ^a   Taylor, Heather J ^a   Mitchell, Ellen Sullivan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE; FOLLITROPIN; TESTOSTERONE;

ADULT; AROUSAL; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; COGNITION; DEPRESSION; FEMALE; HOT FLUSH; HUMAN; MENTAL CONCENTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; SLEEP; SYMPTOMATOLOGY; URINALYSIS; VAGINAL DRYNESS;

ADULT; ANXIETY; BIOLOGICAL MARKERS; DEPRESSION; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HEALTH STATUS; HOT FLASHES; HUMANS; MEMORY DISORDERS; MIDDLE AGED; POSTMENOPAUSE; REGRESSION ANALYSIS; SLEEP DISORDERS; TESTOSTERONE; UNITED STATES; VAGINA; WOMEN'S HEALTH;

EID: 34447617356     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0138     Document Type: Article

References (58)

1. Woods NF, Mitchell ES. Anticipating menopause: Observations from the Seattle Midlife Women's Health Study. Menopause 1999;6:167.
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321.
3. The women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trail. JAMA 2004;291:1701.
4. Carpenter J, Neal J. Other complementary and alternative medicine modalities: Acupuncture, magnets, Reflexology, and Homeopathy. Am J Med 2005;118:109S.
5. Woods NF, Mitchell ES. Symptoms during perimenopause: Prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118:14S.
6. Casper R, Yen S, Wilkes M. Menopausal flushes: A neuroendocrine link with pulsatile luteinizing hormone secretion. Science 1979;205:823.
7. Freedman R. Hot flashes: Behavioral treatments, mechanisms, and relation to sleep. Am J Med 2005;118:124S.
8. Guthrie J, Dennerstein L, Hopper J, Burger H. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996;88:437.
9. Guthrie J, Dennerstein L, Taffe J, Lehert P, Burger H. Hot flushes during the menopause transition: A longitudinal study in Australian-born women. Menopause 2005;12:460.
10. Randolph J, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90:6106.
11. Freeman E, Sammel M, Grisso J, Battistini M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: Risk factors for African American and Caucasian women. J Womens Health Gend Based Med 2001;10:67.
12. Overlie I, Moen M, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 2002;41:69.
13. Meldrum D, Tataryn I, Frumar A, Erlik Y, Lu K, Judd H. Gonadotropins, estrogens, and adrenal steroids during the menopausal hot flash. J Clin Endocrinol Metab 1980;50:685.
14. Tataryn I, Meldrum D, Lu K, Frumar A., Judd H. LH, FSH, and skin temperature during menopausal hot flash. J Clin Endocrinol Metab 1979;49:152.
15. Freedman R, Roehrs T. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004;82:138.
16. Kravitz H, Janssen I, Santoro N, et al. Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med 2005;165:2370.
17. Hollander L, Freeman E, Sammel M, Berlin J, Grisso J, Battistini M. Sleep quality, estradiol levels and behavioral factors in late reproductive age women. Obstet Gynecol 2001;98:391.
18. Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62.
19. Freeman E, Sammel M, Lin H, Nelson D. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375.
20. Avis NE, Crawford S, Stellato R, et al. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4:243.
21. Morrison M, Have T, Freeman E, et al. DHEAS levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years. Biol Psychiatry 2001;50:705.
22. Schmidt P, Murphy J, Haq N, Danaceau M, Simpson St. Clair L. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 2002;27:907.
23. Bromberger JT, Assmann SF, Avis NE, et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003;158:347.
24. Bromberger J, Harlow S, Avis N, et al. Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: The Study of Women's Health Across the Nation (SWAN). Am J Public Health 2004;94:1378.
25. Bromberger J, Meyer P, Kravitz H, et al. Psychologic distress and natural menopause: A multiethnic community study. Am J Public Health 2001;92:1435.
26. Woods NF, Mitchell ES, Adams C. Memory functioning among midlife women: Observations from the Seattle Midlife Women's Health Study. Menopause 2000;7:257.
27. Mitchell ES, Woods NF. Midlife women's attributions about perceived memory changes: Observations from the Seattle Midlife Womens Health Study. J Women's Health Gend Based Med 2001;10:351.
28. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463.
29. Meyer PM, Powell LH, Wilson RS, et al. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 2003;61:801.
30. Shumaker SA, Legault C, Thal L, et al., for the Women's Health Initiative Memory Study Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003;289:2651.
31. Shumaker SA, Legault C, Kuller L, et al., for the Women's Health Initiative Memory Study Investigators. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947.
32. Dennerstein L, Lehert P. Modeling mid-aged women's sexual functioning: A prospective, population-based study. J Sex Marital Ther 2004;30:173.
33. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;779(Suppl 4):S42.
34. Avis NE, Stellato R, Crawford S, Johannes C, Longcope C. Is there an association between menopause status and sexual functioning? Menopause 2000;7:297.
35. Gracia C, Sammel M, Freeman E, et al. Predictors of decreased libido in women during the late reproductive years. Menopause 2004;11:144.
36. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: A 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375.
37. Woods N, Carr MC, Tao EY, Taylor HJ, Mitchell ES. Increased urinary cortisol levels during the menopause transition. Menopause 2006;13:212.
38. Mitchell ES, Woods NF, Mariella A. Three stages of menopausal transition from the Seattle Midlife Women's Health Study: Toward a more precise definition. Menopause 2000;7:334.
39. Chiazze L, Brayer FT, Macisco J, Parker M, Duffy B. The length and variability of the human menstrual cycle. JAMA 1968;203:377.
40. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of reproductive aging workshop (STRAW). Climacteric 2001;4:267.
41. Denari JH, Farinati Z, Casas PRF, Oliva A. Determination of ovarian function using first morning urine steroid assays. Obstet Gynecol 1981;58:5.
42. Stanczyk FZ, Miyakawa I, Goebelsmann U. Direct radioimmunoassay of urinary estrogen and pregnandiol glucuronides during the menstrual cycle. Am J Obstet Gynecol 1980;137:443.
43. O'Connor KA, Brindle E, Shofer JB, et al. Statistical correction for non-parallelism in a urinary enzyme immunoassay. J Immunoassay Immunochem 2004;25:259.
44. Lasley BL, Shidleler SE. Methods for evaluating reproductive health of women. Occup Med 1994;9:423.
45. Wilcox AJ, Baird DD, Weinberg CR, et al. The use of biochemical assays in epidemiologic studies of reproduction. Environ Health Perspect 1987;75:29.
46. Robard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem 1974;20:1255.
47. Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet JW, Lasley BL. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 1991;37:838.
48. Tijssen, P. Practice and theory of enzyme immunoassays. Amsterdam: Elsevier Publications, 1985.
49. Chad T. An introduction to RIA and related technologies, 4th ed. Amsterdam: Elsevier Publications, 1990.
50. Dufau ML, Winters CA, Hattori M, et al. Hormonal regulation of androgen production by the leydig cell. J Steroid Biochem 1984;20:161.
51. Taussky HH. A microcolorimetric determination of creatinine in urine by the Jaffe reaction. J Biol Chem 1954;208:853.
52. Tataryn I, Lomax P, Bajorek J, Chesarek W, Meldrum D. Judd H. Postmenopausal hot flushes: A disorder of thermoregulation. Maturitas 1980; 2:101.
53. Randolph J, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90:6106.
54. Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause - A five year prospective study with profiles of gonadotropins, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642.
55. Shaver J, Giblin E, Lentz M, Lee K. Sleep patterns and stability in perimenopausal women. Sleep 1988;11:556.
56. Shaver J, Paulsen V. Sleep, psychological distress, and somatic symptoms in perimenopausal women. Fam Pract Res J 1993;13:373.
57. Young T, Rabago D, Zgierska A, Austin D, Laurel F. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 2003:26:667.
58. Lukacs J, Chilimigras J, Cannon J, Dormire S, Reame N. Midlife women's responses to a hospital sleep challenge: Aging and menopause effects on sleep architecture. J Womens Health 2004;13:333.